Results 141 to 150 of about 47,798 (276)
Postoperative radiotherapy after DCIS: Useful for whom?
, 2017 The number of patients with ductal carcinoma in situ (DCIS) increases with more widely used screening mammography programs. DCIS accounts for approximately 20% of all new breast cancer diagnoses in these programs and the natural course of this ...
Karlsson, Per,, Per Karlsson
core +1 more source
, 2011 Copyright information:Taken from "S100A7 (Psoriasin), highly expressed in Ductal Carcinoma (DCIS), is regulated by IFN-gamma in mammary epithelial cells"http://www.biomedcentral.com/1471-2407/7/205BMC Cancer 2007;7():205-205.Published online 6 Nov ...
Anna Bylander (83715) +3 more
core +1 more source
Biological variables and prognosis of DCIS
The Breast, 2005 Based on current knowledge, biological factors that have been investigated in ductal carcinoma in situ (DCIS) include histology of these lesions, the impact of margin status on local recurrence, and several genetic alterations. Optimal integration of these factors in guiding optimal therapy is of great importance, since the incidence of DCIS is rising ...
openaire +3 more sources
Should palpable DCIS be treated as IDC? A retrospective audit.
, 2011 146 Background: Ductal carcinoma in situ (DCIS) identified by screening mammography accounts for 20% of breast cancer diagnoses, and microinvasion (DCIS-M) is found in 5%-10%. There are no defined treatment guidelines for palpable DCIS or DCIS-M.
V. Vanmali +6 more
core +1 more source
DCIS histopathology from a historical perspective
, 2006 Ductal carcinoma in situ (DCIS) represents a biologically and morphologically heterogeneous disease. It is characterized by a proliferation of presumably epithelial malignant cells confined within the lumens of the mammary ducts, without evidence of ...
Goussia, A. C. +3 more
core
Does the Oncotype DCIS score impact treatment decisions?
, 2013 91 Background: The Oncotype Dx DCIS Score has been developed and validated for risk recurrence in ductal carcinoma in situ. It is a 12 gene assay performed on an individual patient’s tumor.
Paul R. Gliedman +6 more
core +1 more source
Identification of a “highly-aggressive” DCIS subgroup.
, 2014 DCIS lesions are sub-classified according to the molecular subtypes of adjacent TDLU and IDC (Model 1: TDLU and IDC have the same molecular subtypes; Model 2: TDLU and IDC have different molecular subtypes).
Mary B. Daly (196724) +8 more
core +1 more source
Dihedral groups with the m-DCI property
Journal of Algebraic CombinatoricsA Cayley digraph $\rm{Cay}(G,S)$ of a group $G$ with respect to a subset $S$ of $G$ is called a CI-digraph if for any Cayley digraph $\rm{Cay}(G,T)$ isomorphic to $\rm{Cay}(G,S)$, there is an $α\in \rm{Aut}(G)$ such that $S^α=T$. For a positive integer $m$, $G$ is said to have the $m$-DCI property if all Cayley digraphs of $G$ with out-valency $m$ are ...
Jin-Hua Xie +2 more
openaire +2 more sources
World Journal of Surgical OncologyPurpose Ductal carcinoma in situ (DCIS) is considered a precursor to invasive ductal carcinoma (IDC), and the coexistence of DCIS with IDC is often observed during the diagnosis of breast cancer.
Sicheng Zhou +4 more
doaj +1 more source
Integrating radiomics into predictive models for low nuclear grade DCIS using machine learning
Scientific ReportsPredicting low nuclear grade DCIS before surgery can improve treatment choices and patient care, thereby reducing unnecessary treatment. Due to the high heterogeneity of DCIS and the limitations of biopsies in fully characterizing tumors, current ...
Yimin Wu +9 more
doaj +1 more source